Trialbee CEO Matt Walz Named to PharmaVoice100 for Innovation in Clinical Research
been named to the 2022 PharmaVoice 100 — an annual list that recognizes the most inspiring
people in the life-sciences industry – for his work to increase access, diversity, and efficiency in
clinical research.
“With the number of clinical trials over the next five years requiring 125 million patients, it is
imperative that we democratize access to clinical research with a more patient-centric
approach,” says Walz, who has been bringing disruptive software innovations to the life
sciences industry for more than two decades. “At Trialbee, we are drastically improving global
patient recruitment and enrollment by operationalizing real-world data (RWD), simplifying the
patient journey and reducing the burden of enrolling patients for sites.”
In 2021, Walz helped Trialbee launch Trialbee Honey™, its flagship SaaS-based product and
the first solution to track and measure all global recruitment activities while optimizing enrollment
timelines through real-time analytics. Trialbee’s purpose-built platform uses data-driven insights
to improve patient enrollment at global scale.
Walz’s inspired, hands-on approach has helped Trialbee quadruple sales and grow the
employee base to span across eight countries while delivering global recruitment projects with
eight of the top 10 global pharmaceutical companies. Trialbee’s innovative technology and
offerings are available globally in over 48 countries, with active engagements in studies in 24
countries with major CROs, large pharmaceutical companies, and mid-sized biotechs.
“It is always an honor to showcase these inspiring individuals, whose leadership over the past
18 months has been more important than ever to make sure their teams, the patients they
serve, and their organizations continue to excel at the highest levels possible,” said Taren Grom,
PharmaVoice Editor in Chief Emeritus.
PharmaVoice100 selects honorees from a pool of nominations submitted by readers and
evaluated by the PharmaVoice team. This year’s honorees include Legacy Leaders, Tech
Wizards, Innovators, Disrupters, Entrepreneurs, and DE&I Champions.
To recognize these honorees and discuss the challenges faced across the life-sciences industry,
join PharmaVoice on Sept. 15 for a free, full-day virtual event.
About Trialbee
Trialbee is the leading global data and technology platform for patient recruitment and
enrollment in clinical trials. Trialbee Hive™ operationalizes real world data (RWD) and applies
data science to find patients globally. Trialbee Honey™ simplifies the journey into clinical
research for patients, reduces the burden of enrolling patients for sites and provides real-time,
data-driven insights to sponsors and CROs so they can optimize enrollment timelines.
Partnering with sponsors, CROs, and virtual/decentralized sites, and software providers,
Trialbee is achieving patient enrollment goals and driving enhancements in diversity in clinical
trial populations. We are the smartest way to match and enroll patients for your clinical trial. For
more information, visit http://www.trialbee.com or contact us at solutions@trialbee.com.
About PharmaVoice
PharmaVoice is a leading industry publication operated by Industry Dive. Our stories deliver the
most important voices and ideas in the life sciences to industry leaders.
Contacts
Matt McLoughlin
Gregory FCA (for Trialbee)
610.228.2123
Matt@GregoryFCA.com